Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Incidence of cold-induced peripheral neuropathy and dose modification of adjuvant oxaliplatin-based chemotherapy for patients with colorectal cancer

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Intrahepatic Oxaliplatin and Systemic 5-FU +/- Cetuximab in Chemo-Naïve Patients with Liver Metastases from Colorectal Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Dual Inhibition of EGFR and VEGF in Heavily Pretreated Patients with Metastatic Colorectal Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Breast cancer in systemic lupus erythematosus

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Prognostic impact of Charlson's Age-Comorbidity Index and other risk factors in patients with pancreatic cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Effect of dosage of 17ß-estradiol on uterine growth in Turner syndrome - a randomized controlled clinical pilot trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Prognostic Value of Combined Detection of Serum IL6, YKL-40, and C-reactive Protein in Patients with Unresectable Pancreatic Cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. 5-year outcome after complete mesocolic excision for right-sided colon cancer: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: The CAPOX regimen is used for adjuvant treatment of colorectal cancer. A well-known side effect of oxaliplatin, which often leads to dose modification (DM), is acute neuropathy (AN). AN is provoked by cold, and it could therefore be expected that the degree of AN and thereby DM is more pronounced in the winter period compared to the summer period.

METHOD: Patients with colorectal cancer who received adjuvant CAPOX from January 2005 to August 2011 were reviewed. Out of 108 patients who received adjuvant CAPOX, the oxaliplatin dose was reduced in 92 (85%) patients due to AN. Seventeen out of 31 (55%) patients already had a DM of oxaliplatin in the second cycle during the winter period (December to February; mean temperature 0.1-1.8°C), while in the summer period (June to August; mean temperature 15.1-16.3°C), only 4 (13%) patients needed DM (OR = 2.5, p = 0.022).

CONCLUSION: In this study, we found that the risk of DM and discontinuation of oxaliplatin is highest in the winter period compared to the other seasons. This study draws attention to the importance of training in the proper handling of the acute neurotoxicity of oxaliplatin.

Original languageEnglish
JournalOncology
Volume87
Issue number3
Pages (from-to)167-72
Number of pages6
ISSN0030-2414
DOIs
Publication statusPublished - 2014

    Research areas

  • Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Adjuvant, Cold Temperature, Colorectal Neoplasms, Denmark, Deoxycytidine, Dose-Response Relationship, Drug, Female, Fluorouracil, Follow-Up Studies, Humans, Incidence, Liver Neoplasms, Male, Neoplasm Staging, Organoplatinum Compounds, Peripheral Nervous System Diseases, Prognosis, Retrospective Studies

ID: 44960294